HK1079778A1 - New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents
New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HK1079778A1 HK1079778A1 HK05111844A HK05111844A HK1079778A1 HK 1079778 A1 HK1079778 A1 HK 1079778A1 HK 05111844 A HK05111844 A HK 05111844A HK 05111844 A HK05111844 A HK 05111844A HK 1079778 A1 HK1079778 A1 HK 1079778A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- new fluorinated
- benzothiadiazine compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62C—FIRE-FIGHTING
- A62C13/00—Portable extinguishers which are permanently pressurised or pressurised immediately before use
- A62C13/76—Details or accessories
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Business, Economics & Management (AREA)
- Emergency Management (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0400689A FR2865474B1 (fr) | 2004-01-26 | 2004-01-26 | Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1079778A1 true HK1079778A1 (en) | 2006-04-13 |
Family
ID=34630671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05111844A HK1079778A1 (en) | 2004-01-26 | 2005-12-22 | New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |
Country Status (20)
Country | Link |
---|---|
US (1) | US7268129B2 (no) |
EP (1) | EP1557412A1 (no) |
JP (1) | JP4291786B2 (no) |
KR (1) | KR100668195B1 (no) |
CN (1) | CN1308317C (no) |
AR (1) | AR047455A1 (no) |
AU (1) | AU2005200311A1 (no) |
BR (1) | BRPI0500235A (no) |
CA (1) | CA2492161C (no) |
EA (1) | EA009698B1 (no) |
FR (1) | FR2865474B1 (no) |
GE (1) | GEP20063960B (no) |
HK (1) | HK1079778A1 (no) |
MA (1) | MA27545A1 (no) |
MX (1) | MXPA05001019A (no) |
NO (1) | NO20050391L (no) |
NZ (1) | NZ537877A (no) |
SG (1) | SG113569A1 (no) |
UA (1) | UA86574C2 (no) |
ZA (1) | ZA200500774B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2879201B1 (fr) * | 2004-12-10 | 2007-02-16 | Servier Lab | Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AR082618A1 (es) | 2010-08-10 | 2012-12-19 | Takeda Pharmaceutical | Derivados de tiadiazina, composiciones farmaceuticas y usos |
CN102977054A (zh) * | 2012-12-12 | 2013-03-20 | 中国药科大学 | 一类选择性α2A受体激动剂的治疗阿尔茨海默病用途 |
CN114230471B (zh) * | 2021-11-09 | 2024-01-26 | 河北科技大学 | 一种3,4-二氯-2-氟苯胺的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5488049A (en) * | 1993-12-10 | 1996-01-30 | Fidia - Georgetown Institute For The Neuro-Sciences | Method of treating learning and memory disorders using benzothiadiazide derivatives as nootropic agents |
US6083947A (en) * | 1996-01-29 | 2000-07-04 | The Regents Of The University Of California | Method for treating sexual dysfunctions |
AU4345297A (en) * | 1996-09-17 | 1998-04-14 | Regents Of The University Of California, The | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
RU2214405C2 (ru) * | 1998-02-18 | 2003-10-20 | НьюроСёрч А/С | Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов |
FR2801587B1 (fr) * | 1999-11-30 | 2002-01-11 | Adir | Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2003005978A1 (en) * | 2001-07-10 | 2003-01-23 | Sven Jarby | Remedy against skin diseases |
FR2833950B1 (fr) * | 2001-12-21 | 2005-12-16 | Servier Lab | Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2856064B1 (fr) * | 2003-06-13 | 2005-08-19 | Servier Lab | Nouveaux derives de benzothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
2004
- 2004-01-26 FR FR0400689A patent/FR2865474B1/fr not_active Expired - Fee Related
-
2005
- 2005-01-10 CA CA2492161A patent/CA2492161C/fr not_active Expired - Fee Related
- 2005-01-19 SG SG200500253A patent/SG113569A1/en unknown
- 2005-01-24 MA MA28063A patent/MA27545A1/fr unknown
- 2005-01-24 US US11/041,495 patent/US7268129B2/en not_active Expired - Fee Related
- 2005-01-24 GE GEAP8596A patent/GEP20063960B/en unknown
- 2005-01-24 EA EA200500072A patent/EA009698B1/ru not_active IP Right Cessation
- 2005-01-25 EP EP05290160A patent/EP1557412A1/fr not_active Withdrawn
- 2005-01-25 AR ARP050100244A patent/AR047455A1/es unknown
- 2005-01-25 AU AU2005200311A patent/AU2005200311A1/en not_active Abandoned
- 2005-01-25 NO NO20050391A patent/NO20050391L/no not_active Application Discontinuation
- 2005-01-25 KR KR1020050006775A patent/KR100668195B1/ko not_active IP Right Cessation
- 2005-01-25 UA UAA200500666A patent/UA86574C2/ru unknown
- 2005-01-25 NZ NZ537877A patent/NZ537877A/en unknown
- 2005-01-25 MX MXPA05001019A patent/MXPA05001019A/es active IP Right Grant
- 2005-01-26 ZA ZA200500774A patent/ZA200500774B/xx unknown
- 2005-01-26 CN CNB2005100029246A patent/CN1308317C/zh not_active Expired - Fee Related
- 2005-01-26 JP JP2005017813A patent/JP4291786B2/ja not_active Expired - Fee Related
- 2005-01-26 BR BR0500235-4A patent/BRPI0500235A/pt not_active IP Right Cessation
- 2005-12-22 HK HK05111844A patent/HK1079778A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4291786B2 (ja) | 2009-07-08 |
NZ537877A (en) | 2005-10-28 |
US20050165008A1 (en) | 2005-07-28 |
EA200500072A1 (ru) | 2005-08-25 |
CN1308317C (zh) | 2007-04-04 |
NO20050391L (no) | 2005-07-27 |
CA2492161C (fr) | 2010-06-22 |
AU2005200311A1 (en) | 2005-08-11 |
JP2005232166A (ja) | 2005-09-02 |
AR047455A1 (es) | 2006-01-18 |
SG113569A1 (en) | 2005-08-29 |
BRPI0500235A (pt) | 2005-09-06 |
KR20050077028A (ko) | 2005-07-29 |
US7268129B2 (en) | 2007-09-11 |
NO20050391D0 (no) | 2005-01-25 |
UA86574C2 (ru) | 2009-05-12 |
MA27545A1 (fr) | 2005-10-03 |
FR2865474A1 (fr) | 2005-07-29 |
FR2865474B1 (fr) | 2008-06-13 |
EP1557412A1 (fr) | 2005-07-27 |
CA2492161A1 (fr) | 2005-07-26 |
MXPA05001019A (es) | 2007-11-14 |
GEP20063960B (en) | 2006-11-10 |
CN1680343A (zh) | 2005-10-12 |
EA009698B1 (ru) | 2008-02-28 |
KR100668195B1 (ko) | 2007-01-11 |
ZA200500774B (en) | 2005-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL198869A0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A PDGFRa ANTAGONIST | |
SG138588A1 (en) | New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them | |
AP2384A (en) | 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
PL1729739T3 (pl) | Sposób wytwarzania stałej kompozycji farmaceutycznej | |
ZA200801991B (en) | Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds | |
HK1096386A1 (en) | Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
SG121999A1 (en) | New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HUP0401522A2 (en) | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation | |
ZA200603810B (en) | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1086259A1 (en) | New pyrrolidine and thiazolidine compounds, a process for their preparation and pharmaceutical compositions containing them | |
ZA200510022B (en) | Benzothiazine and benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1079778A1 (en) | New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1096097A1 (en) | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1093986A1 (en) | Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1111403A1 (en) | New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them | |
EG24207A (en) | New benzothiazine and benazothiadizine compounds, a process for their preparation and pharmaceuticalcompositions containing them | |
EG24369A (en) | New isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1070360A1 (en) | Benzo ÄaÜpyranoÄ3,2-hÜacridin-7-one compounds, a process for their preparation and pharmaceutical compositions thereof | |
ZA200501010B (en) | BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them. | |
ZA200800833B (en) | New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
SG110170A1 (en) | New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
SG122000A1 (en) | New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1079775A1 (en) | New 4-oxo-4,6,7,8-tetrahydro-pyrrolo Ä1,2-AÜpyrazine-6-carboxamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1098146A1 (en) | New polysubstituted 1,1-pyridylaminocyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them | |
ZA200606277B (en) | Polysubstituted 1,1-pyridyloxycyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110126 |